tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD

Compare Opus Genetics (IRD) vs. Competitors

Compare
1,235 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Opus Genetics
$2.00
$137.93M
-1.16
37.93%
9 Buy
0 Hold
0 Sell
Strong Buy
Ovid Therapeutics
$1.73
$123.20M
-3.38
90.32%
8 Buy
0 Hold
0 Sell
Strong Buy
Shattuck Labs
$4.64
$293.62M
-4.55
277.24%
2 Buy
2 Hold
0 Sell
Moderate Buy
Inhibikase Therapeutics
$1.67
$202.52M
-2.93
-46.13%
4 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$19.06
$163.37M
-0.87
48.79%
3 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$1.34
$94.74M
-0.56
-68.62%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IRD
Opus Genetics
2.00
0.79
65.29%
OVID
Ovid Therapeutics
1.73
0.93
116.25%
STTK
Shattuck Labs
4.64
3.45
289.92%
IKT
Inhibikase Therapeutics
1.67
-0.99
-37.22%
SRZN
Surrozen
19.06
7.74
68.37%
BMEA
Biomea Fusion
1.34
-2.81
-67.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts